Search

Home > ACC CardiaCast > ACC CardiaCast: Emerging Data in SGLT2 Inhibitors
Podcast: ACC CardiaCast
Episode:

ACC CardiaCast: Emerging Data in SGLT2 Inhibitors
Category: Science & Medicine
Duration: 00:11:43
Publish Date: 2018-06-29 12:47:24
Description:

This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial will help prepare you to better treat your patients.
Total Play: 0